Man Group
COGT icon

Man Group’s Cogent Biosciences COGT Stock Holding History

Man Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.5M Sell
167,858
-26,943
-14% -$943K 0.01% 1002
2026
Q1 		$7.5M Sell
194,801
-97,281
-33% -$3.59M 0.01% 954
2025
Q4 		$10.4M Buy
+292,082
New +$8.21M 0.02% 779

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Man Group's COGT Position: Q2 2026 in Review

Man Group reduced its Cogent Biosciences (COGT) stake by 14% in Q2 2026, selling an estimated $943K and leaving 167,858 shares worth $6.5M. The position accounts for 0.01% of the portfolio, ranked #1002.

Man Group first reported a position in COGT in Q4 2025 and has held it in 3 quarters since. The position peaked at $10.4M in Q4 2025. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Man Group held 167,858 shares of Cogent Biosciences worth $6.5M as of Q2 2026.
  • Man Group sold 26,943 Cogent Biosciences shares in Q2 2026, an estimated $943K.
  • Cogent Biosciences made up 0.01% of Man Group's portfolio in Q2 2026, its #1002 holding.
  • Man Group first reported a position in Cogent Biosciences in Q4 2025 and has held it in 3 quarters since.
  • Man Group's Cogent Biosciences position peaked at $10.4M in Q4 2025.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.